4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents
A Standard patent application filed on 21 December 1992 credited to Hamanaka, Ernest S

Details

Application number :

33233  

Application type :

Standard  

Application status :

LAPSED  

Under opposition :

No  

Proceeding type :

 

Invention title :

4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents  

Inventor :

Hamanaka, Ernest S  

Agent name :

SPRUSON & FERGUSON  

Address for service :

GPO Box 3898 SYDNEY NSW 2001  

Filing date :

21 December 1992  

Associated companies :

 

Applicant name :

Pfizer Inc.  

Applicant address :

235 East 42nd Street New York New York 10017 United States Of America  

Old name :

 

Original Source :

Go  

Same Inventor

• 4-aryl-3-(heteroarylureido)quinoline derivatives
• New (N)-aryl and (N)-heteroarylurea derivatives as inhibitors of...
• BIS-HYDROXYMETHYL CARBONATE BRIDGE PENICILLIN
• BIS-HYDROXYMETHYL CARBONATE BRIDGE PENICILLIN
• PENICILLIN INTERMEDIATES